Slide 1: Executive Summary

Macroeconomic Indicators

Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)

Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Aug 2013 - Jan 2014)

Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction

Slide 5: Clinical Trials - Drug Development Overview

Slide 6: Clinical Trials - Role of Contract Research Organizations

Market Overview

Slide 7: Clinical Trials - Global Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)

Slide 8: Clinical Trials - Market Overview, and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)

Slide 9: Clinical Trials - Overview of Clinical Trials Registered, Cost of conducting Clinical Trials and Distribution of Clinical Trials according to therapeutic areas

Slide 10: Clinical Trials - Distribution of Clinical Trials on the basis phase and Overview of Pharmaceutical Companies conducting Clinical Trials

Drivers & Challenges

Slide 11: Clinical Trials - Drivers and Challenges summary

Slide 12-16: Drivers

Slide 17-19: Challenges

Government Participation

Slide 20: Classification of Clinical Trials for the purpose of approval

Slide 21: Overview of the Schedule Y of the Drugs and Cosmetics Act

Slide 22: Overview of the amendments in Schedule Y

Slide 23: Overview of the ICMR guidelines

Competitive Landscape

Clinical Research Organizations

Slide 24: Porter's Five Forces Analysis

Slide 25-28: Competitive Benchmarking (FY 2013)

Slide 29-68: Major Private Players

Clinical Research Institutes

Slide 69-71: Major Research Organizations

Recent Developments

Slide 72: Recent Developments

Strategic Recommendations

Slide 73-75: Strategic Recommendations

Appendix

Slide 76-77: Ratio and Calculations and Secondary Research

Netscribes' latest market research report titled Clinical Trials Market in India 2014 analyses how India is a potential global hub for conducting clinical trials by Indian as well as global pharmaceutical companies. Clinical trials are conducted on humans to examine the efficacy and safety of new drugs, treatments, therapies and new medical devices before launching them in the market. It is a necessary and final step for the completion of the drug development process. The market is divided into four phases - Phase I, Phase II, Phase III and Phase IV. Contract Research Organizations (CROs) are responsible for designing, monitoring, and managing clinical trials. The market is dominated by private players and foreign pharmaceutical companies.
The clinical research market in India has comparative advantage in conducting clinical trials regarding cost efficiency and a vast population suffering from acute chronic diseases. Government regulations regarding the compensation rule and approval time are hampering the market at present, but the situation is expected to improve soon. Apart from the pharma companies there are several research institutes involved in R&D of clinical trials. Increasing partnerships and changes in the regulatory environment are crucial future driving factors for this market.